Informed consent, bioethical equipoise, and hypoplastic left heart syndrome

Constantine Mavroudis, Constantine D. Mavroudis, Ruth M. Farrell, Marshall L Jacobs, Jeffrey P. Jacobs, Eric D. Kodish

Research output: Contribution to journalArticle

Abstract

In utero diagnosis of complex progressive cardiac disease such as hypoplastic left heart syndrome presents a novel opportunity for antepartum, intrapartum, and neonatal management. The clinical possibilities and potential for differing outcomes challenge the mother-foetus dyad with regard to informed consent. Previous studies reveal that rates of termination of pregnancy for foetuses with hypoplastic left heart syndrome vary widely in the United States and Europe, leading us to surmise that informed consent may be practised differently. The purpose of this paper is to review the ethical considerations and physician responsibilities of informed consent as they relate to prenatal and postnatal patients with hypoplastic left heart syndrome. Special consideration is paid to the informed consent process as practised by the obstetrician, perinatologist, paediatric cardiologist, and paediatric cardiac surgeon as it relates to termination of pregnancy, comfort care, and surgical palliation. We will argue that informed consent as it relates to hypoplastic left heart syndrome is far from standardised and that there exists a state of bioethical equipoise concerning the extent and limits of its application in the current clinical setting.

Original languageEnglish (US)
Pages (from-to)133-140
Number of pages8
JournalCardiology in the Young
Volume21
Issue numberSUPPL. 2
DOIs
StatePublished - Dec 2011
Externally publishedYes

Fingerprint

Hypoplastic Left Heart Syndrome
Informed Consent
Fetus
Ethical Review
Pediatrics
Pregnancy Rate
Heart Diseases
Mothers
boldenone undecylenate
Physicians
Pregnancy

Keywords

  • comfort care
  • foetal diagnosis
  • Norwood
  • pregnancy termination
  • single-ventricle repair
  • surgical palliation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pediatrics, Perinatology, and Child Health

Cite this

Informed consent, bioethical equipoise, and hypoplastic left heart syndrome. / Mavroudis, Constantine; Mavroudis, Constantine D.; Farrell, Ruth M.; Jacobs, Marshall L; Jacobs, Jeffrey P.; Kodish, Eric D.

In: Cardiology in the Young, Vol. 21, No. SUPPL. 2, 12.2011, p. 133-140.

Research output: Contribution to journalArticle

Mavroudis, Constantine ; Mavroudis, Constantine D. ; Farrell, Ruth M. ; Jacobs, Marshall L ; Jacobs, Jeffrey P. ; Kodish, Eric D. / Informed consent, bioethical equipoise, and hypoplastic left heart syndrome. In: Cardiology in the Young. 2011 ; Vol. 21, No. SUPPL. 2. pp. 133-140.
@article{2453a4ff1c0545619c775ebbcf313384,
title = "Informed consent, bioethical equipoise, and hypoplastic left heart syndrome",
abstract = "In utero diagnosis of complex progressive cardiac disease such as hypoplastic left heart syndrome presents a novel opportunity for antepartum, intrapartum, and neonatal management. The clinical possibilities and potential for differing outcomes challenge the mother-foetus dyad with regard to informed consent. Previous studies reveal that rates of termination of pregnancy for foetuses with hypoplastic left heart syndrome vary widely in the United States and Europe, leading us to surmise that informed consent may be practised differently. The purpose of this paper is to review the ethical considerations and physician responsibilities of informed consent as they relate to prenatal and postnatal patients with hypoplastic left heart syndrome. Special consideration is paid to the informed consent process as practised by the obstetrician, perinatologist, paediatric cardiologist, and paediatric cardiac surgeon as it relates to termination of pregnancy, comfort care, and surgical palliation. We will argue that informed consent as it relates to hypoplastic left heart syndrome is far from standardised and that there exists a state of bioethical equipoise concerning the extent and limits of its application in the current clinical setting.",
keywords = "comfort care, foetal diagnosis, Norwood, pregnancy termination, single-ventricle repair, surgical palliation",
author = "Constantine Mavroudis and Mavroudis, {Constantine D.} and Farrell, {Ruth M.} and Jacobs, {Marshall L} and Jacobs, {Jeffrey P.} and Kodish, {Eric D.}",
year = "2011",
month = "12",
doi = "10.1017/S1047951111001715",
language = "English (US)",
volume = "21",
pages = "133--140",
journal = "Cardiology in the Young",
issn = "1047-9511",
publisher = "Cambridge University Press",
number = "SUPPL. 2",

}

TY - JOUR

T1 - Informed consent, bioethical equipoise, and hypoplastic left heart syndrome

AU - Mavroudis, Constantine

AU - Mavroudis, Constantine D.

AU - Farrell, Ruth M.

AU - Jacobs, Marshall L

AU - Jacobs, Jeffrey P.

AU - Kodish, Eric D.

PY - 2011/12

Y1 - 2011/12

N2 - In utero diagnosis of complex progressive cardiac disease such as hypoplastic left heart syndrome presents a novel opportunity for antepartum, intrapartum, and neonatal management. The clinical possibilities and potential for differing outcomes challenge the mother-foetus dyad with regard to informed consent. Previous studies reveal that rates of termination of pregnancy for foetuses with hypoplastic left heart syndrome vary widely in the United States and Europe, leading us to surmise that informed consent may be practised differently. The purpose of this paper is to review the ethical considerations and physician responsibilities of informed consent as they relate to prenatal and postnatal patients with hypoplastic left heart syndrome. Special consideration is paid to the informed consent process as practised by the obstetrician, perinatologist, paediatric cardiologist, and paediatric cardiac surgeon as it relates to termination of pregnancy, comfort care, and surgical palliation. We will argue that informed consent as it relates to hypoplastic left heart syndrome is far from standardised and that there exists a state of bioethical equipoise concerning the extent and limits of its application in the current clinical setting.

AB - In utero diagnosis of complex progressive cardiac disease such as hypoplastic left heart syndrome presents a novel opportunity for antepartum, intrapartum, and neonatal management. The clinical possibilities and potential for differing outcomes challenge the mother-foetus dyad with regard to informed consent. Previous studies reveal that rates of termination of pregnancy for foetuses with hypoplastic left heart syndrome vary widely in the United States and Europe, leading us to surmise that informed consent may be practised differently. The purpose of this paper is to review the ethical considerations and physician responsibilities of informed consent as they relate to prenatal and postnatal patients with hypoplastic left heart syndrome. Special consideration is paid to the informed consent process as practised by the obstetrician, perinatologist, paediatric cardiologist, and paediatric cardiac surgeon as it relates to termination of pregnancy, comfort care, and surgical palliation. We will argue that informed consent as it relates to hypoplastic left heart syndrome is far from standardised and that there exists a state of bioethical equipoise concerning the extent and limits of its application in the current clinical setting.

KW - comfort care

KW - foetal diagnosis

KW - Norwood

KW - pregnancy termination

KW - single-ventricle repair

KW - surgical palliation

UR - http://www.scopus.com/inward/record.url?scp=83755188296&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=83755188296&partnerID=8YFLogxK

U2 - 10.1017/S1047951111001715

DO - 10.1017/S1047951111001715

M3 - Article

C2 - 22152540

AN - SCOPUS:83755188296

VL - 21

SP - 133

EP - 140

JO - Cardiology in the Young

JF - Cardiology in the Young

SN - 1047-9511

IS - SUPPL. 2

ER -